The DOI matches its Crossref record.
Dissociation of immune responses to the ss‐a (ro) 52‐kd and 60‐kd polypeptides in systemic lupus erythematosus and sjögren's syndrome
Abstract
The cellular RNA particle SS‐A (Ro) is a target of autoimmune response in many patients with Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE). Recent immunologic, biochemical, and DNA cloning studies have shown that the SS‐A particle consists of at least 2 polypeptide components, of 52 kd and 60 kd. Immunodiffusion analysis of 60 sera from patients with primary SS revealed 47 (78%) to be SS‐A precipitin positive. Western blotting studies of the sera showed 3 groups of reactivities: 22 (47%) possessed autoantibodies against both the 60‐kd and the 52‐kd polypeptides, 19 (40%) reacted only with the 52‐kd protein, and 6 (13%) were nonreactive in Western blots although positive in immunodiffusion. Fifty‐one of 90 SLE sera (57%) were SS‐A precipitin positive by immunodiffusion. In Western blots, 24 (47%) possessed antibodies against both the 60‐kd and the 52‐kd antigens, while 9 (18%) reacted only with the 60‐kd protein. Eighteen (35%) were nonreactive by Western blot, although positive by immunodiffusion. Antibody to the 52‐kd antigen without concomitant antibody to the 60‐kd antigen was seen only in patients with primary SS, whereas antibody to the 60‐kd antigen without concomitant antibody to the 52‐kd antigen was seen only in SLE patients. Although antibodies to SS‐A are detected in both SS and SLE, our findings show that there is dissociation of immune responses to the 2 component antigens of the particle, which may be evidence of different events initiating the autoimmune process in these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Xerostomia and the Geriatric Patient
Ship, J. A., Pillemer, S. R., & Baum, B. J. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50123.x · Cited by 456
Autoantibody profiles in the sera of European patients with myositis
Brouwer, R., Hengstman, G. J. D., Egberts, W. V., Ehrfeld, H., Bozic, B., Ghirardello, A., Grøndal, G., Hietarinta, M., Isenberg, D., Kalden, J. R., et al. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.2.116 · Cited by 409
Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function
James, L. C., Keeble, A. H., Khan, Z., Rhodes, D. A., & Trowsdale, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609174104 · Cited by 386
Fox, R. I., Michelson, P., Casiano, C. A., Hayashi, J., & Stern, M. (2000) · Clinics in Dermatology · doi:10.1016/s0738-081x(00)00135-8 · Cited by 355
Self-citationXerostomia: Clinical Aspects and Treatment
Cassolato, S. F., & Turnbull, R. S. (2003) · Gerodontology · doi:10.1111/j.1741-2358.2003.00064.x · Cited by 349
Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen.
Chan, E. K., Hamel, J. C., Buyon, J. P., & Tan, E. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115003 · Cited by 324
Self-citationTRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis
Pan, J.-A., Sun, Y., Jiang, Y.-P., Bott, A. J., Jaber, N., Dou, Z., Yang, B., Chen, J.-S., Catanzaro, J. M., Du, C., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.007 · Cited by 265
Tripartite-motif proteins and innate immune regulation
McNab, F. W., Rajsbaum, R., Stoye, J. P., & O’Garra, A. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.10.021 · Cited by 263
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress
Gjølberg, T. T., Mester, S., Calamera, G., Telstad, J. S., Sandlie, I., & Andersen, J. T. (2025) · BioDrugs · doi:10.1007/s40259-025-00708-2 · Cited by 20
Metadata
- Authors
- Ben‐Chetrit, E., Fox, R. I., & Tan, E. M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1990-03
- Volume
- 33
- Issue
- 3
- Pages
- 349-355
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2067319956
- Cited by
- 162
- References
- 0
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.